| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0055 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |